Read now on pennbizreport.com • June 24, 2020
Category: BIOMEDICAL
HLS Therapeutics to become distributor of the Saladax MyCare™ psychiatry line including the Insite point-of-care device and antipsychotic reagents
Read now on newswire.ca • June 1, 2020
AVROBIO to collaborate with Saladax Biomedical on new high-speed diagnostic assay
Read now on BusinessWire.com • May 4, 2020
Inslee: State’s investment in Vancouver’s AbSci is money well-spent
Read now on Columbian.com • February 20, 2020
AbSci closes $15.4 M in Series D funding to accelerate growth and scale
Read now on OleanTimesHerald.com • January 13, 2020
Vancouver biotech raises $10M funding round, inks manufacturing deal
Read now on BizJournals.com • January 7, 2020
Studies feature clinical validations of clozapine point of care testing using a single drop of blood to aid psychiatrists in better treatment of patients with schizophrenia
Read now on ValdostaDailyTimes.com • October 24, 2019
S.W. Washington biotech continues to grow rapidly
Read now on BizJournals.com • September 16, 2019
Readers React: Pennsylvania is falling behind in business innovation
Read now on mcall.com • September 7, 2019
Saladax develops first-ever rapid test for an antipsychotic drug using a single drop of blood to aid psychiatrists in the treatment of schizophrenia
Read now on BusinessWire.com • September 5, 2019
Columbia Ventures Corporation 